Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Management and Core Advisors Team

Larry Rodriguez is the company’s President/CEO and also a member of the Board of Directors.  Mr. Rodriguez is an executive with years of experience building and launching new companies across multiple industries. He has successfully led three companies to no less than 400% growth including two start-ups and a Fortune 100 company. Leading the sales and marketing efforts for Southern Optical, the company grew to one of the largest wholesales labs in the U.S. Mr. Rodriguez left the optical industry for nine years joining Capital One developing the growth plan for a division of Capital One that led to 26x growth over seven years growing the company from $500 million in annual revenue to over $13 billion. During that period Capital One was recognized as one of the 5 fastest growing companies in the U.S.  Prior to joining HPO, Mr. Rodriguez served as Senior Vice President for PixelOptics, Inc.  Mr. Rodriguez led the Global Marketing, Sales and Professional Affairs efforts for emPower! the world’s first electronic focusing eyewear. Mr. Rodriguez is a proven leader that has quickly focused organizations on the critical business triggers that will drive profitable growth.

 

Michael Packard- Mr. Packard is the Chairman of the Board of Directors of HPO. In late 1999, Mr. Packard created his own firm, TransCat Consulting, helping organizations “make change that matters.” In addition to his consulting roles, Mr. Packard has filled the interim CEO or general manager roles of several clients. From 1989-1999, Mr. Packard’s role as Executive VP and Chief Administrative Officer at LensCrafters was key to creating the most successful optical retailer in the world and one of the most successful U.S. retailers. In addition to his roles at LensCrafters (1987-1999) and Procter & Gamble (1971-1987), Mr. Packard was the key outside Director on the Board of Innotech, Inc., a high-tech optical company from 1992-1997. He has a Chemical Engineering Degree from Bucknell University (1970) and an MBA from Virginia (1972). Continuing education includes the Change Leadership Program from Wharton and the Retail Executive Program from Harvard.

Andrew W. Ishak O.D., F.A.A.O. - Dr Ishak is the Chief Visionary Officer, and member of the Board of Directors of HPO. Dr. Ishak is the inventor of the technology and conceived of the business market opportunity/need for HPO. His background as President of Bayz Polarized Sunwear lead to the development of the science behind HPO for its proprietary selective light wavelength filtering technology. His ability to network with key individuals in the vision care industry and coordinate their activities from R+D, to prototyping, and securing IP has bolstered the potential for HPO success. He holds several patents with multiple applications pending. Dr. Ishak is also Vice President of Vision Associates, one of the largest private professional optometric practices in the mid-Atlantic region of the U.S. He is a published author, and graduated from the Pennsylvania College of Optometry in 1987.

Sean P. Mcginnis, Ph.D. - Dr. McGinnis is an Entrepreneurial Scientific Advisor and Chief Technology Officer for HPO. He is a researcher skilled in optical thin films and processing with expertise in understanding sustainable manufacturing processes. From 1998 -2005, Dr. McGinnis was an R&D research scientist, project lead, and group leader in the areas of scratch resistant, anti-reflective, tintable, hydrophobic, and other functional coatings and manufacturing processes for ophthalmic lenses for Johnson & Johnson’s Spectacle Lens Group. Dr. McGinnis is a Senior Research Scientist at Virginia Polytechnic Institute and State University. He received his Ph.D. in Materials Science and Engineering from Stanford University.

Peter Haaland, Ph.D. - Dr. Haaland is a founding General Partner of InnerProduct Partners.  He also serves as the Chief Science Officer for two technology startups (one pursuing hand hygiene monitoring technology and a second for a new class of natural gas fuel tanks), and as the CEO of a venture developing radioisotope synthesis at the point-of-care. From 2007-2011, Dr. Haaland conceived and executed high-risk, high-payoff research programs to ensure the future success of the nation's intelligence and defense enterprises. He developed new methods for mapping the chemical composition of the atmosphere, and was broadly engaged in addressing nuclear, chemical, biological, radiological, and cyber threats to national security. Dr. Haaland is an entrepreneurial scientist and inventor with successful developents in fire suppression, ophthalmic lens coating technology, semiconductor processing, scalable databases and thin film optical filter design. He holds A.B., A.M., and Ph.D. degress in chemistry from Harvard.

Mark Mattison-Shupnick - Mr. Mattison-Shupnick is New Product Consultant for HPO. His areas of expertise are market research, product development, project management and ophthalmic optics training for the industry. His clients include major lens manufacturers, regional and national chains, lens processing laboratories, as well as optometric management consulting and buying groups. Mr. Mattison-Shupnick coordinates the continuing education program for 20/20 Magazine, Jobson Publishing, LLC, the largest trade publisher in the ophthalmic industry. Mr. Mattison-Shupnick has earned the rare title of Master Optician and is a globally recognized consultant, speaker, and trainer.

HPO Advisors

Ronald Blum is Founder and Chairman of The Egg Factory, LLC. He is also the Founder & Senior Advisor of PixelOptics. He has had great success in building diverse management teams needed to develop products as well as executing business strategies. He is a visionary, innovator and businessman. Dr. Blum is named as the inventor on over 500 patents and patent applications worldwide. He has been on the editorial advisory boards of two national vision care industry publications. Dr. Blum has also had substantial commercial innovation success, including Innotech which, was sold in 1997 to Johnson and Johnson. Innotech was founded by Dr. Blum in 1990, and under his direction as Chairman and Chief Executive Officer was taken public on the NASDAQ exchange in 1996 before being sold in 1997. Dr. Blum remained with Johnson & Johnson until March 1999 serving as General Manager of Advanced Technologies for the Spectacle Lens Group of Johnson & Johnson, where he lead and managed the team that invented and developed the Definity (Progressive Addition Lens). The Definity Lens was acquired in 2005 by Essilor (the largest lens manufacturer in the world). Prior to founding Innotech, Inc., Dr. Blum founded in 1977, Drs. Blum, Newman, Blackstock & Associates, Optometrists, P.C. By the time of Dr. Blum's departure in 1992, Drs. Blum, Newman, Blackstock & Associates, Optometrists, P.C., had grown to be one of the largest multi-location private professional optometric practices in the Southeastern United States. In 1999 Dr. Blum was presented by the Mayor of Roanoke, Virginia a Key to the City, as well as, by the Governor of Virginia honorary shares in the original trading company of Jamestown, Virginia founded in 1607. Dr. Blum recently served on the Board of Trustees for Roanoke College.

 

William Burns - Mr. Burns serves as: Advisor of Marketing and Advertising for HPO. He is currently President/CEO of Encore, Inc, an early startup in the pharmaceutical arena. From Jan. 2000- June 2005 Mr. Burns served as Vice President of Global Marketing, Consumer and Pharmaceutical Products for Alcon where he directed the brand launch of Systane Lubricant Eye Drops worldwide and directed the team market plan launch of Optifree, the Contact Lens Care Solution line. During this time Mr. Burns represented $600 million of the $4 billion dollars sales of Alcon products. From Jan. 1996- Dec. 1999 Mr. Burns served as Vice President of International Marketing, Pharmaceutical and Consumer Products for Alcon where he directed the preparation of Alcon’s first global launch for the anti-glaucoma drug Travatan, which have current sales of $200 million. Mr. Burns has a Bachelor of Arts from Slippery Rock University with a Major in Biology and Minor in Chemistry. He attended the Program for Management Development from the Harvard Business School and the Framework for Strategic Thinking and Planning from Columbia University.

Dan Durrie, M.D. – Dr. Durrie the leader of the Durrie Vision refractive surgery team. With more than 20 years of experience, he is an internationally known pioneer in procedures to correct nearsightedness, farsightedness, and astigmatism. He is based in Kansa City, and is Clinical Professor Ophthalmology at the University of Kansas Medical Center. Dr. Durrie has been recognized as one of the top 10 refractive surgeons in the nation. His scientific articles and papers have appeared in numerous medical professional publications and he is on the editorial board of Ocular Surgery News, The Journal of Ophthalmology and Refractive Surgery, and the Review of Ophthalmology and Refractive Eyecare for Ophthalmologists. Dr. Durrie has given hundreds of presentations for professional organizations world-wide.

John Hunkeler, M.D. – Dr. Hunkeler is founder and medical director of Hunkeler Eye Institute. Specializing in cataract and lens implant surgery, Dr. Hunkeler has maintained a private practice in the metropolitan Kansas City area since 1973. Dr. Hunkeler has helped educate ophthalmologists throughout the world in the technique of small incision cataract surgery. He was the first surgeon to use the YAG laser in Kansas City in 1984 and the excimer laser in 1988. In October 1996, he was recognized by Ophthalmology Times as one of the top 100 ophthalmologists in the United States. In 1977, Dr. Hunkeler was the founding director of the Kansas City Eye Bank and served as its medical director for the next 10 years. He also served as a medical monitor for the laser photorefractive keratectomy study for nearsightedness. Additionally, Dr. Hunkeler has facilitated the use of Hunkeler Eye Institute as the national training facility for physicians interested in learning about excimer laser procedures in refractive surgery procedures. As chairman of the Department of Ophthalmology at the University of Kansas School of Medicine, Dr. Hunkeler oversees the training of ophthalmology residents at the school. Dr. Hunkeler earned his medical degree from the University of Kansas and continued his medical training with an internship at the Los Angeles County Hospital and subsequent ophthalmic residency at the University of Kansas. Also, he has held leadership roles in many ophthalmic organizations and served on the boards of the Outpatient Ophthalmic Surgery Society, the American Board of Eye Surgery, and the Eye Bank Association of America. Dr. Hunkeler is a board-certified ophthalmologist and past president of the American Society for Cataract and Refractive Surgery.

Richard Lindstrom, M.D. - Dr. Lindstrom is founder and managing partner of Minnesota Eye Consultants, is a board-certified ophthalmologist and internationally recognized leader in corneal, refractive and laser surgery. He has been at the forefront of ophthalmology's evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon. Dr. Lindstrom graduated Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, and continued on to complete his doctorate degree in medicine in 1972. In 1980, Dr. Lindstrom returned to the University of Minnesota, where he spent ten years on the faculty of the Department of Ophthalmology, the last two as the Harold G. Scheie Research Chair. He entered private practice in 1990, and has led the growth and expansion of Minnesota Eye Consultants as managing partner. Dr. Lindstrom conceptualized the Phillips Eye Institute Center for Teaching and Research in Minneapolis, a state-of-the-art ophthalmic research and surgical skills education facility, and serves as its medical director. He continues to play an active role in teaching and training at the Phillips Eye Institute and the University of Minnesota. Dr. Lindstrom also serves as medical director and board member of Laser Vision Centers, Inc., and Midwest Surgical Services, as well as associate director of the Minnesota Lions Eye Bank. Dr. Lindstrom holds 28 patents in ophthalmology, including intraocular lens implant technology, corneal preservation, irrigation solutions, viscoelastic solutions, intracorneal lenses and associated surgical instruments. He has designed a number of intraocular lenses and instruments that are used in clinical practices globally. A frequent lecturer throughout the world on cornea, cataract and refractive surgery, he has presented 28 named lectures and keynote speeches before professional societies in the U.S. and abroad.

James Schumer, M.D. - Dr. Schumer is a practicing ophthalmologist in Columbus Ohio. His particular area of interest has been in clinical ophthalmology -- specializing in cornea, external disease, and refractive surgery. Throughout the years, he has been involved in ophthalmic research to help advance patient care and assist industry in bringing devices to market. Dr. Schumer graduated from the Medical College of Ohio, followed by an internship at the Oakwood Hospital and residency at the Henry Ford Hospital (both in Detroit, Michigan). He then served a fellowship at the Hunkeler Eye Clinic in Kansas City, Missouri. Since then, Dr. Schumer has continued to be active in research and publishing in the area of retinal surgery and devices, as well as his ophthalmology practice.

Leo P. Semes, OD, FAAO, FACMO - Leo P. Semes, OD, is Professor of Optometry at UAB. He earned his OD from PCO and completed residency at The Eye Institute of PCO. Dr. Semes has authored or over 220 scientific articles, book chapters and posters. He is a fellow of the American Academy of Optometry, as well as an active member of the AOA, chairing the Nutrition and Health Committee. Dr. Semes is a founding member of the Optometric Glaucoma Society and a founding fellow of the Optometric Retina Society. Disclosure: I serve on the advisory board or speakers’ bureau of Alcon, Allergen, Optovue, Med Op. 01/18/12 (and the previous 12 months)

Janet Sparrow, Ph.D. - Dr. Sparrow is a Scientific Advisor for HPO (though receiving no compensation of any kind). She is a Professor of Ophthalmic Science and currently Director of the Retinal Cell Biology Laboratory at the Edward S. Harkness Eye Institute at Columbia University. She is internationally recognized, respected, and published for her work in identifying specific retinal photochemical byproducts and their correlation with HEVL damage and AMD. Dr. Sparrow was instrumental in determining the functionality characteristics for the “Restor” intra-ocular lens recently released from Alcon. She has received the following awards: Research to Prevent Blindness, Lew R. Wasserman Merit Award, and the Alcon Research Institute Award.